My youngest of three daughters, Hannah, has an ultra-rare genetic disorder called Giant Axonal Neuropathy (GAN). She was diagnosed following her fourth birthday, and she is now 11. GAN is taking it’s tole on Hannah. She has scoliosis and is losing strength in her trunk. She can barely walk with the help of two adults. She is choking on water. She is losing muscle mass in her arms and legs. She sleeps with a cpap.
Hannah is afraid to sleep alone. For the past two years, I have been sleeping with her. I love the time we have alone together each night. I hate it that she is so dependent, as this frustrates her and it isn’t fair that she has this disorder. I am angry to my core, but I love the tight bond and special relationship we have because she is dependent.
NORD is honored to tell Lori’s story as part of our celebration of moms this Mother’s Day (#myraremomstory).
To make a donation in honor of a mom in your life this Mother’s Day, please visit our Donate page.
By Lisa Phelps, NORD Director of Marketing & Community Relations
With every New Year comes the resolve of individuals to better themselves in one or more ways. But after the ball has dropped and the confetti is swept away, it’s difficult for 75% of people to remain committed to their resolutions beyond the first week!
This year, consider a resolution to which you can remain committed: Resolve to better the lives (and chance at life) for 30 million individuals – not just one.
Rare Disease Day is only eight weeks after New Year’s Day, falling on February 28, 2015. On this one-of-a-kind day, communities around the world will gather together to raise awareness among the general public and decision-makers about the 7,000+ rare diseases and their impact on the lives of patients. Started by EURORDIS and brought to the US by NORD in 2009, this pivotal day has contributed to national plans and policies to better the lives of patients in over 80 countries.
The New Year’s Resolution: Become a Rare Disease Day Partner and join the 30 million Americans impacted by a rare disease to help patients, caregivers, and organizations working to advance the availability and delivery of information, research, education, treatment and care.
1. You Can Donate to support events and activities by patients and advocates
2. You Can Help Host a State House Event, or join one already in planning
3. You Can Share the Rare Disease Day Message with friends and decision-makers through social media, media/press, or in writing to your elected official
4. You Can Submit a Handprints Across America™ photo – using either your photo, or, if you’re feeling ambitious, find influential public figures to take a photo with the Handprints Across America™ handout! The most influential photo will be included in NORD’s 2015 media campaign with a story on the individual or group that submitted.
Let’s Achieve Our New Year’s Goals Together.
“Alone We Are Rare. Together We Are Strong.”™
As the holidays are in full swing, I cannot help but reflect upon the number of courageous families who are facing the most challenging times of their lives as they are impacted by rare diseases.
The Christmas season is a poignant one for me as I celebrate everything for which I am thankful and remember the fond memories of years past with my family. I also reflect upon the memory of my son, Trevor, who never had a chance at life as he was afflicted with a devastating rare disease called Metachromatic Leukodystrophy.
This neurological, progressive, degenerative disorder claimed his young life, robbing him of the simple pleasures we all enjoy: the ability to talk, walk, play ball, dance and simply grow up as we all should.
Every day, in my mind, I see his smiling face and behind him the silhouettes of 30 million Americans. Every day, I wake up and undertake my mission as parent advocate and the Director of Development of NORD.
Before members of Congress pack up and go home for the holidays in December, there’s one important thing they need to do: Complete the reauthorization of the Newborn Screening Saves Lives Act.
At the start of this Congressional year, reauthorization of this very successful legislation appeared to be a slam-dunk. The value of the Newborn Screening Saves Lives Act has been well documented.
Both the House and Senate passed reauthorization bills with little fanfare. But now the legislation has become stalled in the Senate, and it is not at all certain that the impasse will be resolved before the end of this Congressional season.
To leave this critically important matter in limbo would be a disservice to all Americans … and, in particular, to the rare disease community.
The Monaco family’s story illustrates why newborn screening is important. In 2001, son Stephen went to bed one evening a lively and precocious toddler. By morning, he was in medical crisis, his life forever compromised by a “silent” disease that no one knew he had.
Stephen’s sister, Caroline, leads a normal, active life today as a result of newborn screening that made possible proactive measures to protect her. In addition to the tragic loss of Stephen’s ability to fulfill his early promise, this story also has an economic component. Stephen will need a lifetime of sophisticated medical care, whereas a major part of Caroline’s treatment is simply a modified diet.
On behalf of all the Stephens and Carolines in this world, NORD is inviting everyone to join us in letting Congress know that newborn screening is important to us. We have sent a letter to Congress signed by more than 70 organizations and rare disease medical experts.
In addition, our policy team has drafted an email that you can easily personalize and send to your Congressional representatives today. Please consider joining us in this important effort.
NORD and Frontline Medical Communications have signed a strategic partnership agreement to collaborate and develop innovative educational programs for physicians and other healthcare providers (HCPs). read more >
RareDisease Dialog is the official blog for the National Organization for Rare Disorders (NORD). NORD’s staff and friends will share information of interest to the entire rare disease community.
Translate This page:
SUBSCRIBE TO OUR E-NEWS